‌Blood Cancers & Blood Disorders

Blood Cancer & Blood Disorders

John Burke, MD

SCRI at Rocky Mountain Cancer Centers I The US Oncology Network, is coauthor on the Late Breaking Abstract, “frontMIND: Phase 3 Study of Tafasitamab plus Lenalidomide and R-CHOP for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma,” that will be presented on Saturday, May 30 at 3:00 p.m. CDT as part of the session, Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia in the Arie Crown Theater.

Click here to learn more about Dr. Burke.